$1.28
-0.12-8.57%
At close: Nov 13, 4:00 PM EST
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals Ltd.
CLRPFOTCPK
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals fell 52.4% from $2.69 to $1.28, behind the S&P 500's +12.3%. Its worst day was Jul 21 (−17.6%), and its low came Nov 4 at $1.06.
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals shares rose 22.9%, while the S&P 500 rose 0.2%.
+22.9% · S&P 500 +0.2%
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals closed at its highest level of the year, 1.1% above where the year started.
Story events cover the past 12 months · Times ET
+13.6% · S&P 500 −0.1%
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals shares rose 31.4%, while the S&P 500 fell 0.1%.
+31.4% · S&P 500 −0.1%
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals shares rose 36.9%, while the S&P 500 fell 0.2%.
+36.9%, the year's best day · S&P 500 −0.2%
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals closed at its lowest level of the year, 60.6% below where the year started.
−3.6% · S&P 500 +1.7%
Where it ended: a close of $1.28 on Nov 13, 2026.
Nothing in the past 12 months.
All CLRPF earningsNothing in the past 12 months.
All CLRPF analyst actionsNothing in the past 12 months.
All CLRPF dividend historyNothing in the past 12 months.
All CLRPF news
